Several brokerages have updated their recommendations and price targets on shares of Intellia Therapeutics (NASDAQ: NTLA) in the last few weeks: 11/22/2025 – Intellia Therapeutics was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating. 11/12/2025 – Intellia Therapeutics had its “peer perform” rating reaffirmed by analysts at Wolfe [...]
Recent Investment Analysts’ Ratings Changes for Intellia Therapeutics (NTLA)
